Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
4.120
-0.130 (-3.06%)
Oct 14, 2025, 9:55 AM EDT - Market open
Genfit Market Cap
Genfit has a market cap or net worth of $212.02 million as of October 14, 2025. Its market cap has decreased by -19.32% in one year.
Market Cap
212.02M
Enterprise Value
248.35M
1-Year Change
-19.32%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since February 5, 2013, Genfit's market cap has increased from $103.68M to $212.02M, an increase of 104.49%. That is a compound annual growth rate of 5.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 212.02M | 16.18% |
| Dec 31, 2024 | 182.50M | -6.18% |
| Dec 29, 2023 | 194.52M | -7.62% |
| Dec 30, 2022 | 210.57M | -13.73% |
| Dec 31, 2021 | 244.08M | 28.79% |
| Dec 31, 2020 | 189.52M | -75.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |